Immdal Ltd Announces Sale of Subsidiary Newport

October 20, 2011 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

DUBLIN--(BUSINESS WIRE)--Immdal Limited (‘Immdal’), a privately held Irish pharmaceutical healthcare group, today announced the sale of its subsidiary Newport Pharmaceuticals Limited (‘Newport’) to Swiss pharmaceutical company Ewopharma AG.

Twitter
LinkedIn
Facebook
Email
Print

Mergers & acquisitions Europe